Assessing Breast Cancer Risk and BRCA1/2 Carrier Probability

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Breast Disease

• Publication date

  2007-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/BD-2007-27102PMID 17917138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ductal carcinoma in situ in BRCA mutation carriers.

  2007cited by this paper
• Genetic/familial high-risk assessment: breast and ovarian.

  2006cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.

  2005cited by this paper
• BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

  2005cited by this paper
• Update on the Manchester Scoring System for BRCA1 and BRCA2 testing

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• Understanding breast cancer risk ‐ where do we stand in 2005?

  2005cited by this paper
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement

  2005cited by this paper
• The BOADICEA model of genetic susceptibility to breast and ovarian cancer

  2004cited by this paper
• Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families

  2004cited by this paper
• Referral for cancer genetics consultation: a review and compilation of risk assessment criteria

  2004cited by this paper
• Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors

  2004cited by this paper
• A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

  2004cited by this paper
• Hereditary breast cancer in Jews

  2004cited by this paper
• Breast cancer genetics in African Americans

  2003cited by this paper
• Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations

  2003cited by this paper
• American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

  2003cited by this paper
• BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.

  2002influential reference
• BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

  2002cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• The effect of a single BRCA2 mutation on cancer in Iceland

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

  2002cited by this paper
• Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

  2002cited by this paper
• Relevance of high and low penetrance.

  2001cited by this paper
• De novo recurrent germline mutation of theBRCA2 gene in a patient with early onset breast cancer

  2001cited by this paper
• Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.

  2001cited by this paper
• Founder BRCA1 and BRCA2 mutations in early‐onset French Canadian breast cancer cases unselected for family history

  2001cited by this paper
• The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens.

  2001cited by this paper
• Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer

  2001cited by this paper
• Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

  2000cited by this paper
• Ongoing research to identify environmental risk factors in breast carcinoma

  2000cited by this paper
• De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation.

  1999cited by this paper
• Tumor suppressor genes in breast cancer.

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• Evidence for a BRCA1 founder mutation in families of West African ancestry.

  1999cited by this paper
• Cancer risk in close relatives of women with early-onset breast cancer – a population-based incidence study

  1999cited by this paper
• Inherited genetic predisposition in breast cancer

  1999cited by this paper
• Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women.

  1999cited by this paper
• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.

  1998cited by this paper
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998influential reference
• A systematic review and meta‐analysis of family history and risk of ovarian cancer

  1998cited by this paper
• A family with three germline mutations in BRCAl and BRCA2

  1998cited by this paper
• BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

  1997cited by this paper
• Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

  1997cited by this paper
• Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• Family history and the risk of breast cancer: A systematic review and meta‐analysis

  1997cited by this paper
• High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

  1996cited by this paper
• Agreement between breast cancer risk estimation methods.

  1996cited by this paper
• Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries

  1996cited by this paper
• Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• The genetics of breast and ovarian cancer.

  1995cited by this paper
• Validation of the Gail et al. model for predicting individual breast cancer risk.

  1994cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• Neoplastic diseases in families of breast cancer patients.

  1994cited by this paper
• Validation of a breast cancer risk assessment model in women with a positive family history.

  1994cited by this paper
• The calculation of breast cancer risk for women with a first degree family history of ovarian cancer

  1993cited by this paper
• Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer

  1993cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• The evaluation of the data collection process for a multicenter, population-based, case-control design.

  1988cited by this paper
• Breast cancer detection demonstration project: Five‐year summary report

  1982cited by this paper

• Making sense of breast cancer risk estimates

  2024cites this paper
• Assessment of pathogenic variation in gynecologic cancer genes in a national cohort

  2023cites this paper
• Oncology in the Precision Medicine Era: Value-Based Medicine

  2020cites this paper
• Genomic Cancer Risk Assessment

  2019cites this paper
• Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop

  2019cites this paper
• Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan

  2019cites this paper
• First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene.

  2016cites this paper
• The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know.

  2015cites this paper
• Genetically Based Breast Cancer: Risk Assessment, Counseling, and Testing

  2015cites this paper
• Breast Cancer Prevention

  2014cites this paper
• gDNA enrichment by a transposase-based technology for NGS analysis of the whole sequence of BRCA1, BRCA2, and 9 genes involved in DNA damage repair.

  2014cites this paper
• An Investigation of Genetic Counselors’ Testing Recommendations: Pedigree Analysis and the Use of Multiplex Breast Cancer Panel Testing

  2014cites this paper
• Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors

  2012cites this paper
• Genetics, genomics, and cancer risk assessment

  2011cites this paper
• Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?

  2011cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• Clinical application of breast cancer risk assessment models.

  2010cites this paper
• Breast cancer risk communication: Assessment of primary care physicians by standardized patients

  2009cites this paper
• The Contribution of BRCA1 and BRCA2 to Ovarian Cancer

  2009cites this paper